NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market Tuesday that its third quarter revenues increased 3 percent year over year, as gains in its research consumables and applied sciences business groups was offset by a decline in its genetic analysis business.

The Carlsbad, Calif.-based maker of genetic analysis products reported total revenues of $935.1 million for the three months ended Sept. 30, up from $911.2 million. Excluding the impact of currency, life Tech said its revenue were up 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.